AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

$7.90

+$0.41 (+5.47%)

Nov 2, 2026, 9:52 AM ET · Market open

TTM Period Ending	TTM 2026 Jun 30, 2026	TTM 2025 Dec 31, 2025	TTM 2025 Sep 30, 2025	TTM 2024 Dec 31, 2024	TTM 2023 Dec 31, 2023	TTM 2022 Dec 31, 2022
PE Ratio	n/a	-9.74	-16.64	-11.23	-42.75	-62.19
PEG Ratio	n/a	-6.14	n/a	-0.04	-1.05	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	n/a	4.64	3.61	n/a	n/a	n/a
P/FCF Ratio	n/a	-11.74	-20.06	n/a	n/a	n/a
P/OCF Ratio	n/a	-11.74	-20.34	n/a	n/a	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0.01	0.01	n/a	n/a	n/a
Quick Ratio	12.88	6.52	13.99	n/a	n/a	n/a
Current Ratio	12.88	6.52	13.99	n/a	n/a	n/a
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	-41.28	-987.92	-219.10	-716.73	-1.01K	-502.98
Return on Equity	-25.73%	-47.78%	-17.92%	n/a	n/a	n/a
Return on Assets	-22.36%	-40.69%	-18.12%	n/a	n/a	n/a
Return on Invested Capital	-22.03%	-43.79%	-14.48%	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a